President & CEO
(402) 290-4840
mdixon@unmc.edu
Michael Dixon is President and CEO, working with faculty, students and staff to help commercialize innovative, new ideas that have the potential to improve public health in Nebraska and beyond. Dr. Dixon is responsible for setting UNeMed’s strategic path while directing efforts to protect, market and license new technologies.
Dr. Dixon is a graduate of Leadership Omaha Class 32 and a 2011 recipient of the Midlands Business Journal “40 under 40” award. As an active member of the community, Dr. Dixon serves on several Boards of Directors, including Invest Nebraska Corporation, a non-profit, venture development organization that advises and invests in companies and early stage business ideas in Nebraska. He also sits on the board of Bio Nebraska, a nonprofit trade association dedicated to the development and growth of Nebraska’s bioscience industry.
Dr. Dixon holds a doctorate in Pathology and Microbiology from UNMC.
Recent UNeMed news featuring Dr. Dixon:
Idea Pub: Morning Edition will mix Omaha entrepreneur community with University Innovators
OMAHA, Nebraska (April 8, 2024)—The first ever Morning Edition of UNeMed’s Idea Pub is planned for later this month, and plans to help University innovators and entrepreneurs connect and collaborate with colleagues and experts from the venture and startup community. UNeMed, the technology transfer and commercialization office for UNMC and UNO, sponsors the event, which …
University of Nebraska climbs to 73rd on international patent list
OMAHA, Neb. (March 14, 2024)—For the seventh consecutive year, the University of Nebraska landed among the world’s top 100 universities for securing United States patents. All told, innovations created by faculty, students and staff from the University of Nebraska system accounted for 46 U.S. patents issued in the 2023 calendar year. “Innovation is a key …
FDA approves Virtual Incision robot for human use
LINCOLN, Nebraska (February 24, 2024) — The FDA has granted Virtual Incision approval to use its ground-breaking surgical robotics platform, called MIRA, for adult patients undergoing colectomy procedures. FDA approval finally opens the door for the Nebraska-born innovation to be used in hospitals, possibly enabling wider access to minimally invasive procedures to millions of Americans. …
New sampling device created at UNMC gains investment boost
OMAHA, Nebraska (February 20, 2024) — A UNMC startup company announced today a massive boost to its homegrown efforts at reinventing the painful and uncomfortable nasal swabs that so many suffered during the COVID 19 pandemic. University Medical Devices successfully closed a $1.6 million seed round of funding, which will fuel the company’s push to …
UNMC research creates new potential for new Parkinson’s treatment, licenses two patents to Coya Therapeutics
HOUSTON, Texas (February 14, 2024) — An innovative approach to treat Parkinson’s disease, pioneered at the University of Nebraska Medical Center, could reach patients within the next year as a part of a clinical trial. Howard Gendelman, MD, and R. Lee Mosely, PhD, initially identified ld-IL-2 monotherapy — short for low dose interleukin-2 — as …
$2 million EDA grant will help local entrepreneurs, inventors
FORT COLLINS, Colorado (December 11, 2023)—UNeMed and University of Nebraska inventors and entrepreneurs will benefit from a recently announced grant award from the U.S. Economic Development Administration. Based in Ft. Collins, Colo., Innosphere Ventures Regional Life Sciences Incubator was awarded a $2 million grant over three years as a part of the EDA’s 10th cohort …
